Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 869.71B, Eli Lilly(LLY) trades at $920.50. The stock has a price-to-earnings ratio of 40.76 and currently yields dividends of 66.6%.
During the trading session on 2026-04-06, Eli Lilly(LLY) shares reached a daily high of $938.68 and a low of $920.32. At a current price of $920.50, the stock is +0.0% higher than the low and still -1.9% under the high.
Trading volume for Eli Lilly(LLY) stock has reached 946.42K, versus its average volume of 3.28M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Eli Lilly’s Path to $1 Trillion Runs Directly Through the AI Boom By Rich Duprey Published Apr 6, 10:54AM EDT Quick Read Eli Lilly (LLY) generated $65.18B in...
AbbVie ABBV is set to report first-quarter 2026 results on April 29, with investor focus likely to remain on its immunology segment. Following the loss of exclu...
Key Points Foundayo (orforglipron) has a serious advantage over Novo Nordisk's Wegovy pill. Retatrutide, a subcutaneous triple hormone receptor agonist in pha...
Analyst ratings
83%
of 35 ratingsMore LLY News
Over the past two years, Novo Nordisk (NVO +1.23%) has lost its lead in the anti-obesity space to its biggest competitor, Eli Lilly (LLY 1.98%). The Denmark-bas...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...
Eli Lilly (NYSE:LLY) received U.S. FDA approval for Foundayo, its first oral, once-daily GLP-1 weight loss pill for obesity and overweight patients with related...
Direct-to-patient healthcare company Ro announced that it is working with Eli Lilly (LLY) to launch the recently FDA-approved Zepbound KwikPen nationwide on its...
Stocks With Rising Composite Ratings: Eli Lilly 4/01/2026 Eli Lilly saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 93 to 96. 4/01/2...
Eli Lilly And Company (NYSE:LLY) shares are down approximately 1% Thursday despite FDA approval of its oral weight-loss drug Foundayo on Wednesday, as geopoliti...
Eli Lilly (LLY) shares rallied 3.8% in the last trading session to close at $954.52. This move can be attributable to notable volume with a higher number of sha...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.